Solid Biosciences Statistics
Total Valuation
SLDB has a market cap or net worth of $718.77 million. The enterprise value is $389.47 million.
Important Dates
The last earnings date was Wednesday, November 4, 2026, after market close.
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SLDB has 111.61 million shares outstanding. The number of shares has increased by 67.76% in one year.
| Current Share Class | 111.61M |
| Shares Outstanding | 111.61M |
| Shares Change (YoY) | +67.76% |
| Shares Change (QoQ) | +5.11% |
| Owned by Insiders (%) | 0.88% |
| Owned by Institutions (%) | 66.63% |
| Float | 63.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.10 |
| P/TBV Ratio | 2.10 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.99, with a Debt / Equity ratio of 0.06.
| Current Ratio | 11.99 |
| Quick Ratio | 11.46 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -76.87% and return on invested capital (ROIC) is -46.07%.
| Return on Equity (ROE) | -76.87% |
| Return on Assets (ROA) | -41.76% |
| Return on Invested Capital (ROIC) | -46.07% |
| Return on Capital Employed (ROCE) | -61.69% |
| Weighted Average Cost of Capital (WACC) | 18.22% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.78M |
| Employee Count | 121 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.07% in the last 52 weeks. The beta is 2.63, so SLDB's price volatility has been higher than the market average.
| Beta (5Y) | 2.63 |
| 52-Week Price Change | +44.07% |
| 50-Day Moving Average | 6.93 |
| 200-Day Moving Average | 7.68 |
| Relative Strength Index (RSI) | 46.97 |
| Average Volume (20 Days) | 1,293,297 |
Short Selling Information
The latest short interest is 13.30 million, so 11.92% of the outstanding shares have been sold short.
| Short Interest | 13.30M |
| Short Previous Month | 12.30M |
| Short % of Shares Out | 11.92% |
| Short % of Float | 21.02% |
| Short Ratio (days to cover) | 9.70 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -221.75M |
| Pretax Income | -215.27M |
| Net Income | -215.27M |
| EBITDA | -220.08M |
| EBIT | -221.75M |
| Earnings Per Share (EPS) | -$1.72 |
Full Income Statement Balance Sheet
The company has $348.93 million in cash and $19.62 million in debt, with a net cash position of $329.30 million or $2.95 per share.
| Cash & Cash Equivalents | 348.93M |
| Total Debt | 19.62M |
| Net Cash | 329.30M |
| Net Cash Per Share | $2.95 |
| Equity (Book Value) | 342.11M |
| Book Value Per Share | 3.07 |
| Working Capital | 334.74M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$198.92 million and capital expenditures -$1.38 million, giving a free cash flow of -$200.30 million.
| Operating Cash Flow | -198.92M |
| Capital Expenditures | -1.38M |
| Depreciation & Amortization | 1.67M |
| Net Borrowing | -203,000 |
| Free Cash Flow | -200.30M |
| FCF Per Share | -$1.79 |
Full Cash Flow Statement Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SLDB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -67.76% |
| Shareholder Yield | -67.76% |
| Earnings Yield | -26.75% |
| FCF Yield | -27.87% |
Analyst Forecast
The average price target for SLDB is $18.71, which is 190.53% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $18.71 |
| Price Target Difference | 190.53% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
The last stock split was on October 28, 2022. It was a reverse split with a ratio of 1:15.
| Last Split Date | Oct 28, 2022 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |